1-3 of 3
Karen van der Weide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gene Expression Profiling In Leukemic Stem Cell-Enriched AML CD34 + Cell Fraction Identifies Target Genes That Predict Prognosis In Normal Karyotype AML

Carolien M Woolthuis, Hendrik JM de Jonge, Annet Z Vos, Andre B Mulder, MD, Eva van den Berg, P.M. Kluin, MD, PhD, Karen van der Weide, Evelina S. De Bont, MD, PhD, Geert A Huls, MD, PhD, Edo Vellenga, MD, PhD, Jan J. Schuringa, PhD
Journal: Blood
Blood (2010) 116 (21): 952.
https://doi.org/10.1182/blood.V116.21.952.952
Published: 2010
Journal Articles

In Vivo Treatment of AML Patients with High-Dose Simvastatin Inhibits Geranylgeranylation In AML Cells

Karen van der Weide, Susan D.P.W.M. de Jonge-Peeters, Gerwin A. Huls, MD, PhD, Rudolf S.N. Fehrmann, Jan J. Schuringa, PhD, Folkert Kuipers, PhD, Elisabeth G.E. de Vries, MD, PhD, Edo Vellenga, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3280.
https://doi.org/10.1182/blood.V116.21.3280.3280
Published: 2010
Journal Articles

Heterogeneity in Simvastatin-Induced Cytotoxicity in AML Is Related to Differential Ras-Isoprenylation, Rather Than to Blockade of Cholesterol Synthesis.

Karen van der Weide, Patrick M. Korthuis, Folkert Kuipers, Elisabeth G.E. de Vries, Edo Vellenga
Journal: Blood
Blood (2009) 114 (22): 1718.
https://doi.org/10.1182/blood.V114.22.1718.1718
Published: 2009